Related references
Note: Only part of the references are listed.Efficacy and safety of COVID-19 vaccines in older people
Roy L. Soiza et al.
AGE AND AGEING (2021)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
The impact of immuno-aging on SARS-CoV-2 vaccine development
Jennifer Connors et al.
GEROSCIENCE (2021)
Emerging concepts in the science of vaccine adjuvants
Bali Pulendran et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Targeting natural killer cells to enhance vaccine responses
Andrew Cox et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2021)
Lower peripheral blood Toll-like receptor 3 expression is associated with an unfavorable outcome in severe COVID-19 patients
Maria Clara Saad Menezes et al.
SCIENTIFIC REPORTS (2021)
A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction
Chee Wah Tan et al.
NATURE BIOTECHNOLOGY (2020)
Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly
Branca Pereira et al.
FRONTIERS IN IMMUNOLOGY (2020)
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Maheshi N. Ramasamy et al.
LANCET (2020)
I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People
Anna Julia Pietrobon et al.
FRONTIERS IN IMMUNOLOGY (2020)
Influenza Vaccination Induces NK-Cell-Mediated Type-II IFN Response that Regulates Humoral Immunity in an IL-6-Dependent Manner
Yagmur Farsakoglu et al.
CELL REPORTS (2019)
mRNA vaccines - a new era in vaccinology
Norbert Pardi et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Vaccination in the elderly: The challenge of immune changes with aging
Annalisa Ciabattini et al.
SEMINARS IN IMMUNOLOGY (2018)
Vaccinating for natural killer cell effector functions
Helen R. Wagstaffe et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2018)
Vaccine development: From concept to early clinical testing
Anthony L. Cunningham et al.
VACCINE (2016)
Boosting vaccine efficacy the natural (killer) way
Carolyn E. Rydyznski et al.
TRENDS IN IMMUNOLOGY (2015)
Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
Carlos A. DiazGranados et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Vaccine strategies to enhance immune responses in the aged
Julie S. Lefebvre et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
The history of MF59 (R) adjuvant: a phoenix that arose from the ashes
Derek T. O'Hagan et al.
EXPERT REVIEW OF VACCINES (2013)
NK Cells as Effectors of Acquired Immune Responses: Effector CD4+ T Cell-Dependent Activation of NK Cells Following Vaccination
Amir Horowitz et al.
JOURNAL OF IMMUNOLOGY (2010)
Age-Associated Decrease in TLR Function in Primary Human Dendritic Cells Predicts Influenza Vaccine Response
Alexander Panda et al.
JOURNAL OF IMMUNOLOGY (2010)
A double-negative (IgD-CD27-) B cell population is increased in the peripheral blood of elderly people
Giuseppina Colonna-Romano et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2009)
Adenovirus vector induced innate immune responses: Impact upon efficacy and toxicity in gene therapy and vaccine applications
Zachary C. Hartman et al.
VIRUS RESEARCH (2008)
Elevated frequency of gamma interferon-producing NK cells in healthy adults vaccinated against influenza virus
Brian R. Long et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus
Chungwen Wei et al.
JOURNAL OF IMMUNOLOGY (2007)
Share Paper
